A single-inhaler triple therapy improved lung function in adults and adolescents with inadequately controlled asthma and was ...

Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST ...

Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is initiating a Phase 2 ...

For decades, scientists believed molecules called leukotrienes were the main culprits behind asthma’s airway-constricting ...

The Hailie Smartinhaler, from med-tech company Adherium, improves asthma control by ensuring inhalers are used effectively and at the right time. It has been assisting American asthmatics since 2017; ...

A new asthma treatment, depemokimab, has shown promise in reducing exacerbations while maintaining a strong safety profile, according to findings presented at the 2025 American Academy of Allergy, ...

Compared with tezepelumab, solrikitug demonstrated unique epitope binding and superior potency across several assays. Researchers from Uniquity Bio and Mosaic Biosciences conducted head-to-head in ...

New research presented at the 2025 Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI ...

"This is urgent and … it's affecting children now, and the most vulnerable children," she said. According to the Asthma and ...

Thunderstorms have been linked to sharp increases in emergency room visits related to asthma symptoms, University of Kansas ...

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with ...